You are viewing the site in preview mode
Skip to main content
|
Inclusion criteria
|
|
Aged ≥18
|
|
Vitamin C deficiency (due to the underlying cancer disease or treatment)
|
|
Previously confirmed cancer diagnosis with previous or current radiation- and/or chemotherapy
|
|
Total lymphocyte count <1500/μL
|
|
Treatment with iv vitamin C 7.5 g once a week, for a total of 4 doses
|
|
Patient's statement of agreement to use and publish their data for the observational study
|
|
Exclusion criteria (anamnestic)
|
|
Patients who received colony-stimulating factor
|
|
Patients not completing all four doses of iv vitamin C
|
|
Oxalate-urolithiasis, nephrolithiasis
|
|
Renal insufficiency
|
|
Iron-storage disease (thalassemia, hämochromatosis, sideroblastic anaemia)
|
|
Erythrocytic glucose-6-phosphate-dehydrogenase-deficiency
|
|
Pregnancy and lactation
|
